NUS NU SKIN ENTERPRISES, INC.

NYSE Wholesale-Drugs, Proprietaries & Druggists' Sundries DE CIK: 0001021561
AI RATING
SELL
85% Confidence

Investment Thesis

Nu Skin faces critical operational deterioration with revenue declining 14.3% YoY and deeply negative operating (-$3.9M) and free cash flows (-$17.6M), indicating unsustainable cash burn. Most alarmingly, interest coverage of 0.2x reveals the company cannot service its debt burden from operations, creating material solvency risk despite an adequate near-term cash position of $198.7M.

Strengths

  • + Strong gross margin of 66.9% indicates viable product economics and pricing power if operations can be right-sized
  • + Conservative balance sheet with low leverage (Debt/Equity 0.26x) and sufficient liquidity (Current Ratio 2.03x, Cash $198.7M) providing near-term runway
  • + Net income up 209.3% YoY demonstrates operational improvements underway, though from a low base of $1.8M

Risks

  • ! Revenue declining 14.3% YoY with operating margin collapsed to 1.3% and net margin near-zero at 0.6%, indicating severe competitive or demand challenges
  • ! Negative operating cash flow (-$3.9M) and free cash flow (-$17.6M) demonstrate company is burning cash operationally and unsustainable at current trajectory
  • ! Interest coverage ratio of 0.2x is critically inadequate; operating income of $4.0M cannot cover interest expense, forcing reliance on asset depletion or refinancing
  • ! ROE of 0.2% and ROA of 0.1% indicate company destroying shareholder value with minimal returns on capital employed
  • ! High insider form 4 activity (21 filings in 90 days) suggests potential management concern about near-term prospects

Key Metrics to Watch

Financial Metrics

Revenue
320.6M
Net Income
1.8M
EPS (Diluted)
$0.04
Free Cash Flow
-17.6M
Total Assets
1.4B
Cash
198.7M

Profitability Ratios

Gross Margin 66.9%
Operating Margin 1.3%
Net Margin 0.6%
ROE 0.2%
ROA 0.1%
FCF Margin -5.5%

Balance Sheet & Liquidity

Current Ratio
2.03x
Quick Ratio
1.34x
Debt/Equity
0.26x
Debt/Assets
42.3%
Interest Coverage
0.20x
Long-term Debt
203.6M
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: 2026-05-09T12:09:16.161980 | Data as of: 2026-03-31 | Powered by Claude AI